Respiratory Virus Infections After Marrow Transplant: The Fred Hutchinson Cancer Research Center Experience

1997 ◽  
Vol 102 (3) ◽  
pp. 27-30 ◽  
Author(s):  
Raleigh A Bowden, MD
2002 ◽  
Vol 6 ◽  
pp. S26
Author(s):  
C.M. Machado ◽  
L.S. Vilas Boas ◽  
A.V.A. Mendes ◽  
M.F.M. Santos ◽  
D. Sturaro ◽  
...  

1996 ◽  
Vol 22 (5) ◽  
pp. 778-782 ◽  
Author(s):  
E. Whimbey ◽  
R. E. Champlin ◽  
R. B. Couch ◽  
J. A. Englund ◽  
J. M. Goodrich ◽  
...  

2019 ◽  
Vol 11 (5) ◽  
pp. 331-333 ◽  
Author(s):  
Peter J Hotez

Abstract Over the last decade we have seen extraordinary public health gains due to expansions in global vaccination programs led by United Nations (UN) agencies, including Gavi, the Vaccine Alliance, UNICEF and the WHO. These initiatives have reduced childhood deaths from measles, tetanus and other vaccine-preventable diseases by almost one half. There is additional excitement over the potential development and introduction of new vaccines to prevent highly lethal respiratory virus infections, as well as tuberculosis, malaria, HIV/AIDS and several neglected tropical diseases. However, these successes are under threat due to political instability, conflict and an accelerating antivaccine movement. New initiatives in vaccine diplomacy will be required to combat these challenges.


Author(s):  
Heather W Dolby ◽  
Philippe M D Potey ◽  
Annika Wilder-Smith ◽  
Sara Clohisey ◽  
Jonathan E Millar ◽  
...  

Abstract Pulmonary micro-thrombosis and vasculitis occur in fatal COVID-19. To determine if these processes occur in other life-threatening respiratory virus infections we identified autopsy studies of fatal influenza(n=455 patients), SARS(n=37), MERS(n=2), adenovirus(n=34) and RSV(n=30). Histological evidence of thrombosis was frequently present in adults with fatal influenza and SARS, with vasculitis also reported.


Sign in / Sign up

Export Citation Format

Share Document